"Joined-up" approach needed in UK to deliver life sciences strategy
A report published yesterday by IMS Health - which shows the slow progress being made on the uptake of new medicines in the UK - has led the chief of the Association of the British Pharmaceutical Industry (ABPI) to call for a more joined up approach to the government’s life sciences strategy.
The review, titled Bridging the Gap - Why some patients don’t receive NICE recommended treatments in England, lists the numerous barriers to medicines reaching patients and calls for urgent action to remove these obstacles. The findings come one year after the UK government published its Life Sciences strategy, which aimed to boost health and economic indicators by turning round the UK’s poor record on medicines uptake.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
| Headless Content Management with Blaze